共 100 条
[1]
Kanis JA(2019)European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 30 3-44
[2]
Cooper C(2020)Fragility fractures in Europe: burden, management and opportunities Arch Osteoporos 15 59-310
[3]
Rizzoli R(2017)Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project J Intern Med 281 300-77
[4]
Borgström F(2015)Fragility non-hip fracture patients are at risk Arch Orthop Trauma Surg 135 69-2578
[5]
Karlsson L(2015)Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture R Best Practice Framework tool Osteoporos Int 26 2573-259
[6]
Ortsäter G(2019)Osteoporosis The Lancet 32 251-155
[7]
Katsoulis M(2021)The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study Osteoporos Int 6 59-1529
[8]
Benetou V(2011)Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) Arch Osteoporos 28 1507-13
[9]
Karapetyan T(2017)Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures Osteoporos Int 1 1-773
[10]
Gosch M(2020)An updated systematic review of cost-effectiveness analyses of drugs for osteoporosis Pharmacoeconomics 33 759-1452